Pace Pharmaceuticals, Inc. filed a Form D with the Securities and Exchange Commission on 2026-09-28.
Pace Pharmaceuticals, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 28, 2026. The filing reports $50K sold. Its industry group is Biotechnology. It names Douglas Yao (Executive Officer, Director, Promoter) (SEC Form D, September 28, 2026).
Sell to companies like Pace Pharmaceuticals, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-09-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Pace Pharmaceuticals, Inc.
Free to see. No signup.
More on the people and the money behind Pace Pharmaceuticals, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in September 2026, largest first.
Get an email when Pace Pharmaceuticals, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Pace Pharmaceuticals, Inc. raises, hires or launches. No email unless you switch it on.
Watch Pace Pharmaceuticals, Inc. →Get the full cited report on Pace Pharmaceuticals, Inc.
What the filing shows about Pace Pharmaceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Pace Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Pace Pharmaceuticals, Inc. See pricing
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $50K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
Pace Pharmaceuticals integrates AI and laboratory robotics to develop new medicines for neurological disease. Explore our compounds and research.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Douglas Yao is named as Executive Officer and Director and Promoter on the Form D that Pace Pharmaceuticals, Inc. filed with the SEC on 28 September 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-09-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Pace Pharmaceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Pace Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Pace Pharmaceuticals, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Pace Pharmaceuticals, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Pace Pharmaceuticals, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-30 (pacepharmaceuticals.com).
Each opens in a new tab, filled in for Pace Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.
On these lists: San Francisco Bay Area raises, week of 2026-09-28 · Biotech raises, week of 2026-09-28 · Biotech raises in San Francisco Bay Area
https://mentionfox.com/funding/pace-pharmaceuticals-inc-form-d-000001